Single chemotherapy treatment into the bladder after scope
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving one dose of chemotherapy placed directly into the bladder after a diagnostic bladder/urinary scope (URS) can help people with a localized upper urinary tract cancer (UTUC). It may help reduce cancer coming back, alongside standard post-scope care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have localized UTUC (cancer mainly in one area, not spread to distant sites)
- Be able to start the plan: have URS first, then agree to the single chemotherapy dose placed in the bladder
- Not be on any cancer treatment medicines for other cancers at the same time
- No bladder cancer in the past 5 years, and no bladder removal surgery (radical cystectomy)
- Not be pregnant, and have an expected lifespan of at least 1 year (and you should have two functioning kidneys, not only one)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches for people with early-stage bladder cancer that has a low chance of coming back: either careful monitoring without immediate treatment, or receiving chemotherapy directly into the bladder to lower the risk of recurrence. It aims to see if monitoring alone is as good as chemotherapy for those with a low risk detected by a urine test.
This trial tests whether adding targeted radiation therapy to standard drug treatment can help people with urothelial cancer that has spread to a few spots (up to 3 outside the brain). If you are starting your first or second round of systemic therapy, this study may be an option.
This trial tests whether adding radiation therapy to immunotherapy after bladder removal surgery can help prevent cancer from coming back. It's for people with advanced bladder cancer who have already started immunotherapy.
This trial tests whether putting chemotherapy medicine directly into the bladder right after surgery helps prevent bladder cancer from coming back. It compares gemcitabine versus epirubicin given as an immediate bladder “wash-in.”
This study is testing whether giving a single dose of chemotherapy directly into the kidney and ureter right after a scope procedure helps prevent upper urinary tract tumors from coming back. It’s for people who are about to have a scope to diagnose or treat a suspected or known tumor in the upper urinary tract.
This trial tests putting a chemotherapy drug (mitomycin C) directly into the bladder and kidney tube after a diagnostic scope procedure for patients with a suspected upper tract urothelial cancer. It aims to see if this treatment is safe and helps prevent the cancer from coming back.
Hear when a new Upper Urinary Tract Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.